These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32954900)

  • 1. Valuing health outcomes: developing better defaults based on health opportunity costs.
    Ochalek J; Claxton K; Lomas J; Thompson KM
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):729-736. PubMed ID: 32954900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
    Ochalek J; Lomas J
    Clin Ther; 2020 Jan; 42(1):44-59.e2. PubMed ID: 31955967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating a cost-effectiveness threshold for health care decision-making in South Africa.
    Edoka IP; Stacey NK
    Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing a cost-effectiveness threshold for Saudi Arabia.
    Al-Jedai AH; Lomas J; Almudaiheem HY; Al-Ruthia YSH; Alghamdi S; Awad N; Alghamdi A; Alowairdhi MA; Alabdulkarim H; Almadi M; Bunyan RF; Ochalek J
    J Med Econ; 2023; 26(1):128-138. PubMed ID: 36576804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
    Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
    Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach.
    Ochalek J; Wang H; Gu Y; Lomas J; Cutler H; Jin C
    Pharmacoeconomics; 2020 Dec; 38(12):1319-1331. PubMed ID: 32856280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach.
    Moler-Zapata S; Kreif N; Ochalek J; Mirelman AJ; Nadjib M; Suhrcke M
    Appl Health Econ Health Policy; 2022 Nov; 20(6):881-891. PubMed ID: 35997895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000-17: a financial modelling study.
    Su Y; Garcia Baena I; Harle AC; Crosby SW; Micah AE; Siroka A; Sahu M; Tsakalos G; Murray CJL; Floyd K; Dieleman JL
    Lancet Infect Dis; 2020 Aug; 20(8):929-942. PubMed ID: 32334658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
    Woods B; Revill P; Sculpher M; Claxton K
    Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
    Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
    Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is a hospital bed day worth? A contingent valuation study of hospital Chief Executive Officers.
    Page K; Barnett AG; Graves N
    BMC Health Serv Res; 2017 Feb; 17(1):137. PubMed ID: 28196489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local health care expenditure plans and their opportunity costs.
    Karlsberg Schaffer S; Sussex J; Devlin N; Walker A
    Health Policy; 2015 Sep; 119(9):1237-44. PubMed ID: 26251323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic evaluation in health care].
    Zechmeister I; Radlberger P
    Wien Med Wochenschr; 2009; 159(5-6):160-8. PubMed ID: 19343294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
    Edney LC; Haji Ali Afzali H; Cheng TC; Karnon J
    Pharmacoeconomics; 2018 Feb; 36(2):239-252. PubMed ID: 29273843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the benefits of new health services greater than their opportunity costs?
    Edney L; Haji Ali Afzali H; Karnon J
    Aust Health Rev; 2019 Oct; 43(5):508-510. PubMed ID: 30526796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Expenditures Associated With Pollution: Exploratory Methods and Findings.
    Preker AS; Adeyi OO; Lapetra MG; Simon DC; Keuffel E
    Ann Glob Health; 2016; 82(5):711-721. PubMed ID: 28283121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.
    Ochalek J; Lomas J; Claxton K
    BMJ Glob Health; 2018; 3(6):e000964. PubMed ID: 30483412
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.